MEDI-544

N/A

Report date: 2026/03/19 16:57:24

Base Information

Drug NameMEDI-544
Drug Alias NameAnti-CD3/Anti-EphA2 Bispecific T-Cell Engager (Micromet/MedImmune)EphA2-targeting BiTE molecules (Micromet)bscEphA2xCD3MEDI-544
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionT cell surface glycoprotein CD3 modulatorsEphrin type-A receptor 2 modulators
TargetsT cell surface glycoprotein CD3Ephrin type-A receptor 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmgen Research (Munich) Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmgen Research (Munich) GmbhMedimmune LlcAmgen Rockville Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A